L740-0103 Screening compound: 4-{2-[butyl(methyl)amino]-2-oxoethyl}-3-oxo-N~1~-phenyltetrahydro-1(2H)-pyrazinecarboxamide

L740-0103 Screening compound: 4-{2-[butyl(methyl)amino]-2-oxoethyl}-3-oxo-N~1~-phenyltetrahydro-1(2H)-pyrazinecarboxamide
L740-0103 Screening compound: 4-{2-[butyl(methyl)amino]-2-oxoethyl}-3-oxo-N~1~-phenyltetrahydro-1(2H)-pyrazinecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L740-0103
4-{2-[butyl(methyl)amino]-2-oxoethyl}-3-oxo-N~1~-phenyltetrahydro-1(2H)-pyrazinecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L740-0103

Molecular Formula

C18H26N4O3 (C18 H26 N4 O3)

Compound Name

4-{2-[butyl(methyl)amino]-2-oxoethyl}-3-oxo-N~1~-phenyltetrahydro-1(2H)-pyrazinecarboxamide

IUPAC name

n/a

SMILES

CCCCN(C)C(CN(CCN(C1)C(Nc2ccccc2)=O)C1=O)=O

InChI

InChI=1S/C18H26N4O3/c1-3-4-10-20(2)16(23)13-21-11-12-22(14-17(21)24)18(25)19-15-8-6-5-7-9-15/h5-9H,3-4,10-14H2,1-2H3,(H,19,25)

InChI Key

QTLHCVMEKNWMLK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27473335

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

346.43

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

0.911

Distribution Coefficient, logD

0.911

Water Solubility, LogSw

-2.07

Polar Surface Area

58.490

Acid Dissociation Constant (pKa)

14.04

Base Dissociation Constant (pKb)

4.74

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

50.00

L740-0103 in Drug Discovery

Included in Screening Libraries

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • Receptor's ligands
Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Immune system
Targets:
  • Proteases
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with L740-0103 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L740-0103?
Check Price and Availability of L740-0103, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L740-0103 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L740-0103
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L740-0103
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L740-0103 available by request